Gordana Raca, MD, PhD, FACMG

Dr. Raca has many years of experience overseeing molecular and cytogenetic testing in high volume diagnostic laboratories. Her long term clinical and research interest is in molecular and cytogenetic mechanisms of genetic disorders and in molecular and cytogenetic diagnostics. Dr. Raca’s recent focus has been on application of genomic technologies (chromosome microarray analysis and next generation sequencing) in studying hematologic malignancies and genetic diseases. Dr. Raca is certified in both Clinical Cytogenetics and Molecular Diagnostics by the American Board of Medical Genetics and Genomics (ABMGG).
Dr. Raca’s expertise in using genomic assay for diagnostics and research in oncology resulted in an election to the Board of Directors of the Cancer Genomics Consortium, a collaborative group focusing on clinical implementation, standardization and advancement of genomic technologies. Dr. Raca’s commitment to the quality and accuracy of clinical testing is reflected in her service on the American College of Medical Genetics (ACMG) Laboratory Quality Assurance Committee for Clinical Cytogenetics and the College of American Pathologists Cytogenetics Resource Committee. Dr. Raca is a member of the American Society for Clinical Pathology (ASCP) Teleconference Committee for Molecular/Emerging Technology Area, and the American Society of Hematology (ASH) Image Bank Taskforce.